Re-Framing Biotechnology Regulation.

Area of Science:

• Biotechnology
• Genetic Engineering
• Regulatory Science

Background:

• Current biotechnology regulation, the Coordinated Framework for Regulation of Biotechnology, struggles to encompass novel genetic engineering techniques like CRISPR-Cas9.
• The existing framework has limitations in capturing all relevant technologies, ensuring public trust in risk management, and supporting small entities.

Purpose of the Study:

• To propose new legislation for reshaping biotechnology regulation.
• To address the shortcomings of the current regulatory framework.
• To ensure effective oversight of emerging biotechnologies.

Main Methods:

• Analysis of the Coordinated Framework for Regulation of Biotechnology.
• Proposal of legislative reforms.
• Recommendations for agency consolidation and inter-agency consultation.

Main Results:

• Identified key flaws in the existing biotechnology regulatory framework.
• Proposed a risk-based approach to regulation, moving away from technology categories.
• Suggested mechanisms for improved agency coordination, information dissemination, and environmental monitoring.

Conclusions:

• The current regulatory framework is inadequate for advanced biotechnologies.
• Legislative reform is necessary to create a more effective, accessible, and risk-proportionate system.
• Proposed reforms aim to foster innovation while managing risks and addressing societal impacts.